Skip to main content
. 2024 Feb 2;8:e52768. doi: 10.2196/52768

Table 1.

Outcomes investigated in the study.

Aspects Outcomes
Symptom burden
  • Patient-reported symptoms

  • Most burdensome symptomsa

  • Areas of involvement (body parts)

  • Photosensitivity and body imagea

  • Sleep disorders

  • Comorbiditiesa

Overall HRQoLb impact
  • Psychological well-being (positive feelings and negative feelings)

  • Physical well-beinga (mobilitya, activities of daily livinga, recreation and leisure, and role participationa)

  • Impact and functioning (including parental care, burden to or on others, and economic or working capability impacts)a

Treatment experience
  • Current treatment options (nonpharmacological and pharmacological interventions)

  • Treatment options and HRQoL aspects based on treatmenta

  • Level of satisfaction with current treatment optionsa

  • Diagnostic delay and health care availability

  • Coping mechanisms

aOwing to low sample size or insufficient data, these outcomes were not analyzed in the cutaneous lupus erythematosus population.

bHRQoL: health-related quality of life.